Physician profile
Michael Craig Delaughter
NPI 1528242336
$1,589,340.43
in general payments reported to CMS, 2019-2025
21 companies · $221K in 2025
The $221K reported for 2025 was more than what 99% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117K · 2020: $61K · 2021: $22K · 2022: $614K · 2023: $417K · 2024: $138K · 2025: $221K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $495K · Travel and Lodging: $222K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $38K · Food and Beverage: $16K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $494,526.95 |
| Travel and Lodging | $221,662.13 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37,968.75 |
| Food and Beverage | $15,675.62 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,550.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,394,434.55 | 2019-2025 | Amplatzer Amulet, Amplatzer, Jeti All In One Non-Sterile Kit |
| Biosense Webster, INC. | $57,824.70 | 2019-2021 | |
| Boston Scientific Corporation | $39,795.83 | 2019-2025 | Watchman Access System, Watchman |
| E.R. Squibb & Sons, L.L.C. | $31,602.74 | 2019-2021 | |
| Pfizer INC. | $28,308.78 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18,996.21 | 2019-2025 | Lifevest |
| Cardiofocus, INC. | $8,852.61 | 2019 | |
| Medtronic Vascular, INC. | $5,791.31 | 2019-2020 | |
| Medtronic, INC. | $2,357.00 | 2021-2022 | |
| Cardiva Medical, INC. | $327.52 | 2020-2021 | |
| Zoll Respicardia, INC. | $300.94 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $237.74 | 2019-2021 | |
| Cvrx, INC. | $184.53 | 2024 | Barostim Neo System |
| Siemens Medical Solutions USA, INC. | $126.01 | 2022 | |
| Biosig Technologies, INC. | $87.12 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bardy Diagnostics, INC. | $30.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.23 | 2021 | |
| Philips North America LLC | $21.51 | 2020 | |
| Biotronik INC. | $20.48 | 2019 | |
| Amarin Pharma, INC. | $17.62 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Delaughter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.